X

Short Take: Drkoop.com mulls reverse stock split

Health Web site Drkoop.com will have a special meeting of investors Jan. 25 to vote on whether the company should implement a 10-to-1 reverse stock split. A split could help boost the company's low share price and help it avoid removal from the Nasdaq Stock Market. According to a proxy statement filed with the Securities and Exchange Commission, Drkoop intends to plead its case to stay on the Nasdaq at a hearing before that stock market.

Greg Sandoval Former Staff writer
Greg Sandoval covers media and digital entertainment for CNET News. Based in New York, Sandoval is a former reporter for The Washington Post and the Los Angeles Times. E-mail Greg, or follow him on Twitter at @sandoCNET.
Greg Sandoval
Health Web site Drkoop.com will have a special meeting of investors Jan. 25 to vote on whether the company should implement a 10-to-1 reverse stock split. A split could help boost the company's low share price and help it avoid removal from the Nasdaq Stock Market. According to a proxy statement filed with the Securities and Exchange Commission, Drkoop intends to plead its case to stay on the Nasdaq at a hearing before that stock market.